Disclosure Panels Details Page
Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström Macroglobulinemia Panel - Disclosures as of 04/20/2020
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Muhamed Baljevic MD | None | AlphaSights Amgen Inc. Cardinal Health Specialty Solutions Celgene Corporation E1A11: Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE) Exelixis Inc. GLG Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Olson Research Group Inc. Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell/Myeloma Fusions (BMT CTN 1401) Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Natalie Callander MD | Cellectar | Cellectar | None | None | ✔ |
| Erica Campagnaro MD | None | None | None | None | ✔ |
| Jorge Castillo MD | AbbVie, Inc. BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics TG Therapeutics |
BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics Roche Laboratories, Inc. |
None | None | ✔ |
| Jason Chandler MD | None | AbbVie, Inc. George Clinical Janssen Pharmaceutica Products, LP |
None | None | ✔ |
| Caitlin Costello MD | None | Celgene Corporation Millennium Pharmaceuticals, Inc. |
None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | ✔ |
| Yvonne Efebera MD, MPH | None | None | Akcea pharmaceutical Janssen Pharmaceutica Products, LP Takeda Pharmaceuticals North America, Inc. |
None | ✔ |
| Matthew Faiman MD, MBA, FACP | None | None | None | None | ✔ |
| Alfred Garfall MD | Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation Tmunity Therapeutics |
GSK Janssen Pharmaceutica Products, LP Surface Oncology |
None | University of Pennsylvania, royalties on licensed IP in the field of CAR T cell therapy. | ✔ |
| Kelly Godby MD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Kyle Herrmann BSN, RN, OCN | None | None | None | None | ✔ |
| Jens Hillengass MD, PhD | Amgen Inc. Celgene Corporation Janssen Pharmaceutica Products, LP |
Adaptive Biotech Amgen Inc. Janssen Pharmaceutica Products, LP Oncotracker |
None | None | ✔ |
| Leona Holmberg MD, PhD | BiolIne RX Bristol Myers Squibb Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. Merck & Co., Inc. Millennium Pharmaceuticals, Inc. sanofi-aventis U.S. Seattle Genetics, Inc. |
None | None | Up-To-Date | ✔ |
| Myo Htut MD | Celgene Corporation | None | None | None | ✔ |
| Carol Ann Huff MD | Glenmark / Ichnos GSK Karyopharm Therapeutics sanofi-aventis U.S. |
GSK sanofi-aventis U.S. |
None | None | ✔ |
| Yubin Kang MD | Apogee Biotech and RedHill Pharmaceutical Co | None | Takeda Pharmaceuticals North America, Inc. | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Jennifer Keller MS | None | None | None | None | ✔ |
| Rashmi Kumar PhD | None | None | None | None | ✔ |
| Shaji Kumar MD | AbbVie, Inc. Allogene Bristol Myers Squibb Carsgen Celgene Corporation GSK MedImmune Inc. Oncogene Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. Tenebio |
AbbVie, Inc. Celgene Corporation Cellectar Genecentrix Oncopeptides Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Ola Landgren MD, PhD | Amgen Inc. Janssen Pharmaceutica Products, LP Takeda Pharmaceuticals North America, Inc. Theradex |
None | None | None | ✔ |
| Michaela Liedtke MD | Agios, Inc. Allogene Celator Pharmaceuticals Celgene Corporation Genentech, Inc. Janssen Pharmaceutica Products, LP Seattle Genetics, Inc. |
Caelum Celgene Corporation |
Amgen Inc. Pfizer Inc. |
None | ✔ |
| Thomas Martin MD | Amgen Inc. Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Seattle Genetics, Inc. |
GSK | None | None | - |
| Jim Omel MD | none | none | none | none | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Leslie Ray PharmD | None | None | None | None | - |
| Douglas Sborov MD, MSc | None | None | None | None | ✔ |
| Keith Stockerl-Goldstein MD | Cellerant Therapeutics, Inc. | None | None | Abbott Laboratories|AbbVie, Inc.|Novartis Pharmaceuticals Corporation | ✔ |
| Donna Weber MD | None | None | None | None | - |